Skip to main content

Phase 3 randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy and safety of nipocalimab in pregnancies at risk for severe hemolyticdisease of the fetus and newborn (hdfn) - azalea

Open
  • Protocol code: 80202135EBF3001
  • EudraCT code: No aplica
  • Research group: Maternal and Fetal Medicine
  • Service: Obstetrics
  • Principal investigator:  Sánchez Durán, Maria Ángeles
  • Pathology: Embaràs, part i puerperi
  • Phase: Fase III